Selected article for: "acute respiratory and liver metabolic"
Author: Ahmed, Musaab; Ahmed, Mohamed H
Title: Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
  • Cord-id: 5w3zll6f
  • Document date: 2021_6_16
    • ID: 5w3zll6f
    Snippet: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, affecting all the individuals across the planet. COVID-19 has gained significant attention due to its high prevalence among individuals with diabetes, nonalcoholic fatty liver disease (NAFLD), and metabolic syndrome. NAFLD is the hepatic manifestation of metabolic syndrome and can be associated with a high risk of developing type 2 diabetes. The association of
    Document: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, affecting all the individuals across the planet. COVID-19 has gained significant attention due to its high prevalence among individuals with diabetes, nonalcoholic fatty liver disease (NAFLD), and metabolic syndrome. NAFLD is the hepatic manifestation of metabolic syndrome and can be associated with a high risk of developing type 2 diabetes. The association of COVID-19 and NAFLD has also gained more attention because NAFLD is highly associated with the epidemic of obesity. NAFLD is a potential risk factor for SARS-CoV-2 infection and severe COVID-19, independent of metabolic syndrome. Importantly, it is not yet clear whether the epidemics of obesity and NAFLD have perpetuated the current pandemic of COVID-19. Further research is urgently needed to assess the following: (1) Whether NAFLD is a high risk factor for SARS-CoV-2 infection; (2) Whether NAFLD is associated with the severe form of COVID-19; and (3) Whether the presence of NAFLD can explain the racial variation in the morbidity and mortality associated with COVID-19. This review summarizes the interactions between COVID-19 and NAFLD, mechanism of liver injury by COVID-19, and effect of lockdown due to COVID- 19 on patients with NAFLD.

    Search related documents:
    Co phrase search for related documents
    • abdominal liver and adipose abdominal liver: 1, 2, 3
    • abdominal liver and adipose abdominal liver tissue: 1, 2, 3
    • abdominal liver and admission patient: 1
    • abdominal liver and liver cell: 1
    • abdominal liver and liver damage: 1, 2, 3, 4, 5, 6
    • acute kidney injury and additional factor: 1, 2, 3, 4, 5
    • acute kidney injury and admission case: 1, 2, 3, 4
    • acute kidney injury and admission patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute kidney injury and liver damage: 1, 2, 3, 4, 5, 6
    • acute liver injury and additional factor: 1
    • acute liver injury and liver cell: 1, 2, 3, 4, 5, 6, 7
    • acute liver injury and liver damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • additional factor and admission patient: 1
    • additional factor and liver damage: 1, 2
    • additional factor and liver damage cause: 1
    • admission patient and liver damage: 1, 2, 3